BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 9, 2026
Home
»
Topics
»
Infection
» HIV/AIDS
HIV/AIDS
RSS
Novel HIV integrase inhibitors patented by Merck & Co.
Nov. 30, 2006
Long-term activity of tipranavir measured in RESIST trials
Nov. 30, 2006
Studies detail darunavir pharmacokinetic interactions, efficacy
Nov. 30, 2006
Recent Shionogi patent discloses novel therapeutic option for HIV infection
Nov. 24, 2006
Apricitabine has no significant adverse effect on cardiac safety
Nov. 24, 2006
VIR-201 HIV/AIDS vaccine cleared for U.S. phase II trials
Nov. 22, 2006
Recent Tibotec and Trimeris patents report novel agents for HIV infection
Nov. 9, 2006
Phase IIb 28-day monotherapy trial of SP-01A completes enrollment
Nov. 3, 2006
TMC-114 plus ritonavir safe in HIV-hepatitis coinfection
Nov. 2, 2006
Argos awarded NIH contract to further develop HIV immunotherapy candidates
Oct. 31, 2006
Previous
1
2
…
165
166
167
168
169
170
171
172
173
…
423
424
Next